DENTSPLY SIRONA Inc. (XRAY) Forecasted to Earn FY2018 Earnings of $2.95 Per Share
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) – Stock analysts at Barrington Research raised their FY2018 earnings per share (EPS) estimates for shares of DENTSPLY SIRONA in a note issued to investors on Monday. Barrington Research analyst M. Petusky now forecasts that the medical instruments supplier will post earnings per share of $2.95 for the year, up from their prior forecast of $2.78. Barrington Research has a “Outperform” rating and a $73.00 price objective on the stock. Barrington Research also issued estimates for DENTSPLY SIRONA’s FY2019 earnings at $3.35 EPS.
DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings data on Friday, November 3rd. The medical instruments supplier reported $0.70 earnings per share for the quarter, beating analysts’ consensus estimates of $0.66 by $0.04. The company had revenue of $1.01 billion for the quarter, compared to the consensus estimate of $978.99 million. DENTSPLY SIRONA had a positive return on equity of 7.56% and a negative net margin of 20.33%. The company’s quarterly revenue was up 5.8% on a year-over-year basis. During the same period in the previous year, the business earned $0.66 earnings per share.
COPYRIGHT VIOLATION NOTICE: This news story was published by American Banking News and is the property of of American Banking News. If you are viewing this news story on another website, it was illegally copied and republished in violation of U.S. & international copyright & trademark laws. The original version of this news story can be read at https://www.americanbankingnews.com/2017/11/08/dentsply-sirona-inc-xray-forecasted-to-earn-fy2018-earnings-of-2-95-per-share.html.
Several other brokerages have also recently commented on XRAY. BidaskClub cut shares of DENTSPLY SIRONA from a “sell” rating to a “strong sell” rating in a research report on Wednesday, August 16th. Zacks Investment Research upgraded shares of DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a research report on Friday, October 20th. Cleveland Research cut DENTSPLY SIRONA from a “buy” rating to a “neutral” rating in a report on Thursday, October 5th. Credit Suisse Group restated an “outperform” rating and set a $75.00 price objective (up from $67.00) on shares of DENTSPLY SIRONA in a research note on Thursday, July 13th. Finally, UBS AG restated a “neutral” rating and set a $59.00 price objective (down from $62.00) on shares of DENTSPLY SIRONA in a research note on Thursday, August 10th. Three analysts have rated the stock with a sell rating, two have issued a hold rating and seven have issued a buy rating to the company. The stock has a consensus rating of “Hold” and an average target price of $67.00.
DENTSPLY SIRONA (NASDAQ XRAY) traded up $0.13 during trading hours on Wednesday, reaching $64.51. The company’s stock had a trading volume of 1,715,285 shares, compared to its average volume of 2,083,098. DENTSPLY SIRONA has a 12-month low of $52.53 and a 12-month high of $67.95. The company has a debt-to-equity ratio of 0.21, a quick ratio of 1.59 and a current ratio of 2.32. The firm has a market cap of $14,658.28, a P/E ratio of 25.45, a price-to-earnings-growth ratio of 2.62 and a beta of 1.27.
Several large investors have recently bought and sold shares of the company. Sivik Global Healthcare LLC bought a new stake in shares of DENTSPLY SIRONA during the third quarter worth about $2,093,000. ING Groep NV purchased a new position in DENTSPLY SIRONA during the third quarter worth about $434,000. First Interstate Bank purchased a new position in DENTSPLY SIRONA in the third quarter valued at about $164,000. Mawer Investment Management Ltd. boosted its stake in DENTSPLY SIRONA by 2.1% in the third quarter. Mawer Investment Management Ltd. now owns 258,572 shares of the medical instruments supplier’s stock valued at $15,465,000 after acquiring an additional 5,200 shares during the last quarter. Finally, Fuller & Thaler Asset Management Inc. purchased a new position in DENTSPLY SIRONA in the third quarter valued at about $227,000. 93.71% of the stock is owned by institutional investors.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
Receive News & Ratings for DENTSPLY SIRONA Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA Inc. and related companies with MarketBeat.com's FREE daily email newsletter.